论文部分内容阅读
经皮冠状动脉介入治疗使用机械方法使因动脉粥样硬化狭窄的冠状血管腔恢复或部分恢复到原有的大小,但淤积于内皮下的脂质斑块仍需药物来控制与清理。术后用药要以保护心血管,有利于预防新的心血管疾病的发生,有利于防止冠状动脉介入术后再狭窄的发生与发展为原则。我们对抗凝药物、抗血小板制剂、β-受体阻断剂、血管紧张素转换酶抑制剂、硝酸酯、调脂药物以及钙拮抗剂等在接受经皮冠状动脉介入治疗的急性冠脉综合征患者中的应用进行分析探讨。
Percutaneous coronary interventions use mechanical means to restore or partially restore coronary atresia due to atherosclerosis to the original size, but lipid plaque deposited on the endothelium still require medication to control and cleanse. Postoperative medication to protect the cardiovascular, is conducive to the prevention of new cardiovascular diseases, is conducive to prevent the occurrence and development of restenosis after coronary intervention as the principle. We have anticoagulant drugs, antiplatelet agents, β-blockers, angiotensin converting enzyme inhibitors, nitrates, lipid-lowering drugs and calcium antagonists in patients undergoing percutaneous coronary intervention of acute coronary syndrome Application of levy in patients for analysis and discussion.